Quanterix Launches Next Generation Simoa 2.0 Ultrasensitive Immunoassay Platform

Lexington, Mass. –— Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced the launch of Simoa 2.0, its next-generation ultrasensitive immunoassay platform. Simoa 2.0 addresses many customer requests and input collected during the rapid growth of Simoa’s first year and a half on [...]

IDT Launches New Approach to CRISPR with Proven Increase in Genome Editing Potency

CORALVILLE, IA – Integrated DNA Technologies (IDT), introduces a new approach to CRISPR—its innovative Alt-R™ CRISPR-Cas9 System, based on the naturally occurring S. pyogenes CRISPR RNA system. The Alt-R CRISPR-Cas9 System greatly improves genome editing potency thanks to research-optimized crRNAs (CRISPR RNA) and tracrRNAs (trans-activating crRNA). Along with improved potency and safety, the system saves [...]

Miltenyi Biotec and Cesca Therapeutics’ Subsidiary TotipotentRX Announce Multi-Year Commercial Agreement for Bone Marrow Transplantation

RANCHO CORDOVA, Calif. -- Cesca Therapeutics Inc.(KOOL), an autologous cell-based regenerative medicine company, today announced that its subsidiary, TotipotentRX, has signed a multi-year distribution agreement with Miltenyi Biotec GmbH (Germany) for clinical product sales throughout India. As part of the agreement, TotipotentRX's advanced haploidentical transplant program will incorporate Miltenyi Biotec's CliniMACS(R) Cell Separation System, used [...]

Morpho Awarded U.S. Department of Homeland Security R&D Contract for Advanced Itemiser DX Air Cargo Trace Detectors

ANDOVER, Mass. –– Morpho (Safran), through its subsidiary Morpho Detection, today announced a research and development (R&D) contract from the U.S. Department of Homeland Security (DHS) Science and Technology Directorate (S&T) to develop the Advanced Itemiser® DX Air Cargo explosives trace detector (ETD). Under terms of the contract, valued at nearly $1 million, Morpho Detection [...]

SPECTRO Opens New State-of-the-Art Application and Demonstration Laboratory in Irvine, California

IRVINE, CALIF. —— SPECTRO Analytical Instruments, Inc., a leading manufacturer of advanced instruments, has opened a new state-of-the-art application and demonstration laboratory in Irvine, California. SPECTRO developed the laboratory “due to the remarkable growth in demand for application development support and strong interest in our next generation instrument lines,” said Mark Grey, Vice President & [...]

OriGene Technologies Strengthens Antibody Portfolio by Acquiring Acris Antibodies GmbH

Rockville, MD -- OriGene Technologies, Inc. (“OriGene”), an industry leader of genome wide products for research and diagnostic applications, announced today that it has acquired Acris Antibodies GmbH (“Acris Antibodies”), a provider of antibodies and other life science related products. Acris Antibodies sells and distributes research antibodies and related life science products to research, diagnostic [...]

SCIEX Partners with University of Manchester to Develop Biomarker Discovery Centre and Multi-Omics Centre for Precision Medicine

SCIEX, a global leader in life science analytical technologies, has today announced that The University of Manchester, UK, has invested in a large suite of high-end SCIEX mass spectrometers for targeted and next-generation proteomics for its new Stoller Biomarker Discovery Centre. With SCIEX's SWATH® Acquisition technologies, the Centre will be one of the biggest clinical [...]

Agena Bioscience and Diatech Pharmacogenetics Announce Plan to Launch Actionable, Targeted CE-IVD Marked Oncology Assays for Colon, Lung, and Melanoma Treatment

SAN DIEGO, Calif. — Agena Bioscience announced today the planned commercial launch of its CE-IVD marked MassARRAY® Dx PLUS assays for gene-specific mutation testing to aid in the selection of targeted therapy regimens. Agena Bioscience will introduce the first diagnostic kits in partnership with Diatech Pharmacogenetics. The MassARRAY Dx PLUS assays improve upon existing methods [...]

FEI Announces Agreement to Acquire DCG Systems

HILLSBORO, Ore. -- FEI Company (NASDAQ:FEIC) and DCG Systems, Inc. today announced a definitive agreement under which FEI would acquire DCG for $160 million in an all cash transaction. DCG is a leading supplier of electrical fault characterization, localization and editing equipment, serving process development, yield ramp and failure analysis applications for a wide range [...]

InDevR Receives ISO 13485:2003 Certification for Assays, Instrumentation and IVD Products Significant Milestone for BARDA-Funded FluChip-8G Product Development

Boulder, CO –– InDevR, Inc., an innovative life science company dedicated to improving biopharmaceutical and vaccine manufacturing, announced today that they received ISO 13485:2003 certification, an internationally recognized quality standard for medical devices. InDevR achieved ISO 13485:2003 certification following a successful audit of its quality management system and organizational structure by Intertek, a global leader [...]

Access IBO on Knowledge Center